{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:36:32Z","timestamp":1790638592239,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:00:00Z","timestamp":1556582400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:00:00Z","timestamp":1556582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009874","name":"Universit\u00e9 de Sherbrooke","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100009874","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Centre de recherche CHUS"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5611-7","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T12:04:24Z","timestamp":1556625864000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway"],"prefix":"10.1186","volume":"19","author":[{"given":"Isabelle","family":"Matte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perrine","family":"Garde-Granger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Bessette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Pich\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,30]]},"reference":[{"key":"5611_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.5317\/wjog.v5.i1.39","volume":"5","author":"A Pich\u00e9","year":"2016","unstructured":"Pich\u00e9 A. Pathobiological role of MUC16 mucin (CA125) of ovarian cancer: much more than a tumor biomarker. World J Obstet Gynecol. 2016;5:39\u201349.","journal-title":"World J Obstet Gynecol"},{"key":"5611_CR2","doi-asserted-by":"publisher","first-page":"27371","DOI":"10.1074\/jbc.M103554200","volume":"276","author":"BW Yin","year":"2001","unstructured":"Yin BW, Lloyd KO. Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16. J Biol Chem. 2001;276:27371\u20135.","journal-title":"J Biol Chem"},{"key":"5611_CR3","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/ijc.10250","volume":"98","author":"BW Yin","year":"2002","unstructured":"Yin BW, Dnistrian A, Lloyd KO. Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene. Int J Cancer. 2002;98:737\u201340.","journal-title":"Int J Cancer"},{"key":"5611_CR4","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000064032","volume":"23","author":"TJ O\u2019Brien","year":"2002","unstructured":"O\u2019Brien TJ, Beard JB, Underwood LJ, Shigemasa K. The CA125 gene: a newly discovered extension of the glycosylated N-terminal domain doubles the size of this extracellular superstructure. Tumour Biol. 2002;23:154\u201369.","journal-title":"Tumour Biol"},{"key":"5611_CR5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1159\/000050638","volume":"22","author":"TJ O'Brien","year":"2001","unstructured":"O'Brien TJ, Beard JB, Underwood LJ, Dennis RA, Santin AD, York L. The CA125 gene: an extracellular superstructure dominated by repeat sequences. Tumor Biol. 2001;22:348\u201366.","journal-title":"Tumor Biol"},{"key":"5611_CR6","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/bjc.1984.254","volume":"50","author":"PA Canney","year":"1984","unstructured":"Canney PA, Moore M, Wilkinson PM, James RD. Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker. Br J Cancer. 1984;50:765\u20139.","journal-title":"Br J Cancer"},{"key":"5611_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S0002-9378(87)80352-6","volume":"157","author":"IB Vergote","year":"1987","unstructured":"Vergote IB, B\u00f8rmer OP, Abeler VM. Evaluation of serum CA 125 levels in the monitoring of ovarian cancer. Am J Obstet Gynecol. 1987;157:88\u201392.","journal-title":"Am J Obstet Gynecol"},{"key":"5611_CR8","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJM198310133091503","volume":"309","author":"RC Bast Jr","year":"1983","unstructured":"Bast RC Jr, Klug TL, St-John E, Jenison E, Niloff JM, Lazarus H, Berkowitz RS, Leavitt T, Griffiths CT, Parker L, Zurawski VR Jr, Knapp RC. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. New Eng J Med. 1983;309:883\u20137.","journal-title":"New Eng J Med"},{"key":"5611_CR9","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1167\/iovs.07-1081","volume":"49","author":"TD Blalock","year":"2008","unstructured":"Blalock TD, Spurr-Michaud SJ, Tisdale AS, Gipson IK. Release of membrane-associated mucins from ocular surface epithelia. Invest Ophthalmol Vis Sci. 2008;49:1864\u201371.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5611_CR10","doi-asserted-by":"publisher","first-page":"e32418","DOI":"10.1371\/journal.pone.0032418","volume":"73","author":"B Govindarajan","year":"2012","unstructured":"Govindarajan B, Menon BB, Spurr-Michaud S, Rastogi K, Gilmore MS, Argueso P, Gipson IK. A metalloproteinase secreted by Streptococcus pneumonia removes membrane mucin MUC16 from the epithelial glycocalyx barrier. PLoS One. 2012;73:e32418.","journal-title":"PLoS One"},{"key":"5611_CR11","doi-asserted-by":"publisher","first-page":"9759","DOI":"10.1038\/srep09759","volume":"5","author":"S Das","year":"2015","unstructured":"Das S, Majhi PD, Al-Mugotir MH, Rachagani S, Sorgen P, Batra SK. Membrane proximal ectodomain cleavage of MUC16 occurs in the acidifying Golgi\/post-Golgi compartments. Sci Rep. 2015;5:9759.","journal-title":"Sci Rep"},{"key":"5611_CR12","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/nrc2761","volume":"9","author":"DW Kufe","year":"2009","unstructured":"Kufe DW. Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer. 2009;9:874\u201385.","journal-title":"Nat Rev Cancer"},{"key":"5611_CR13","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.ygyno.2011.02.020","volume":"121","author":"C Th\u00e9riault","year":"2011","unstructured":"Th\u00e9riault C, Pinard M, Comamala M, Migneault M, Beaudin J, Matte I, Boivin M, Pich\u00e9 A, Rancourt C. MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis. Gynecol Oncol. 2011;121:434\u201343.","journal-title":"Gynecol Oncol"},{"key":"5611_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3892\/ijo.2014.2707","volume":"46","author":"P Giannakouros","year":"2015","unstructured":"Giannakouros P, Matte I, Rancourt C, Pich\u00e9 A. Transformation of NIH3T3 mouse fibroblast cells by MUC16 mucin (CA125) is driven by its cytoplasmic tail. Int J Oncol. 2015;46:91\u20138.","journal-title":"Int J Oncol"},{"key":"5611_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ejcb.2013.10.005","volume":"92","author":"K Akita","year":"2013","unstructured":"Akita K, Tanaka M, Tanida S, Mori Y, Toda M, Nakada H. CA125\/MUC16 interacts with Src family kinases, and over-expression of its C-terminal fragment in human epithelial cancer cells reduces cell-cell adhesion. Eur J Cell Biol. 2013;92:257\u201363.","journal-title":"Eur J Cell Biol"},{"key":"5611_CR16","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.ejca.2011.07.004","volume":"48","author":"S Reinartz","year":"2012","unstructured":"Reinartz S, Failer S, Schuell T, Wagner U. CA125 (MUC16) gene silencing suppresses growth properties of ovarian and breast cancer cells. Eur J Cancer. 2012;48:1558\u201369.","journal-title":"Eur J Cancer"},{"key":"5611_CR17","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.18632\/oncotarget.3308","volume":"6","author":"S Das","year":"2015","unstructured":"Das S, Rachagani S, Torres-Gonzalez MP, Lakshmanan I, Majhi PD, Smith LM, Wagner KU, Batra SK. Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells. Oncotarget. 2015;6:5772\u201387.","journal-title":"Oncotarget"},{"key":"5611_CR18","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/onc.2011.297","volume":"31","author":"I Lakshmanan","year":"2012","unstructured":"Lakshmanan I, Ponnusamy MP, Das S, Chakraborty D, Haridas D, Mukhopadhyay P, Lele SM, Batra SK. MUC16 induced rapid G2\/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells. Oncogene. 2012;31:805\u201317.","journal-title":"Oncogene"},{"key":"5611_CR19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ygyno.2009.08.007","volume":"115","author":"M Boivin","year":"2009","unstructured":"Boivin M, Lane D, Pich\u00e9 A, Rancourt C. CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis. Gynecol Oncol. 2009;115:407\u201313.","journal-title":"Gynecol Oncol"},{"key":"5611_CR20","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/1471-2407-14-234","volume":"14","author":"I Matte","year":"2014","unstructured":"Matte I, Lane D, Boivin M, Rancourt C, Pich\u00e9 A. MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL R2 expression and increasing c-FLIP expression. BMC Cancer. 2014;14:234.","journal-title":"BMC Cancer"},{"key":"5611_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1476-4598-13-129","volume":"13","author":"M Felder","year":"2014","unstructured":"Felder M, Kapur A, Gonzalez-Bosquet J, Horibata S, Heintz J, Albrecht R, Fass L, Kaur J, Hu K, Shojaei H, Whelan RJ, Patankar MS. MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress. Mol Cancer. 2014;13:129.","journal-title":"Mol Cancer"},{"key":"5611_CR22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/00004347-198303000-00005","volume":"2","author":"SE Kabawat","year":"1983","unstructured":"Kabawat SE, Bast RC Jr, Bhan AK, Welch WR, Knapp RC, Colvin RB. Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125. Int J Gynecol Pathol. 1983;2:275\u201385.","journal-title":"Int J Gynecol Pathol"},{"key":"5611_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1177\/172460089801300407","volume":"13","author":"M Nap","year":"1998","unstructured":"Nap M. Immunohistochemistry of CA125. Unusual expression in normal tissues, distribution in the human fetus and questions around its application in diagnostic pathology. Int J Biol Markers. 1998;13:210\u20135.","journal-title":"Int J Biol Markers"},{"key":"5611_CR24","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1006\/gyno.1996.0253","volume":"62","author":"AG Zeimet","year":"1996","unstructured":"Zeimet AG, Marth C, Offner FA, Obrist P, Uhl-Steidl M, Feichtinger H, Stadlmann S, Daxenbichler G, Dapunt O. Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA125. Gynecol Oncol. 1996;62:384\u20139.","journal-title":"Gynecol Oncol"},{"key":"5611_CR25","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3747\/pdi.2012.00320","volume":"33","author":"H Cheema","year":"2013","unstructured":"Cheema H, Bargman JM. Cancer antigen 125 as a biomarker in peritoneal dialysis: mesothelial cell health or death? Perit Dial Int. 2013;33:349\u201352.","journal-title":"Perit Dial Int"},{"key":"5611_CR26","doi-asserted-by":"crossref","first-page":"14871","DOI":"10.18632\/oncotarget.7652","volume":"12","author":"M Morgado","year":"2016","unstructured":"Morgado M, Sutton MN, Simmons M, Warren CR, Lu Z, Constantinou PE, Liu J, Francis LL, Conlan RS, Bast RC, Carson DD. Tumor necrosis factor-\u03b1 and interferon-\u03b3 stimulate MUC16 (CA125) expression in breast, endometrial and ovarian cancers through NF\u03baB. Oncotarget. 2016;12:14871\u201384.","journal-title":"Oncotarget"},{"key":"5611_CR27","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.1210\/en.2004-0399","volume":"145","author":"A Thathiah","year":"2004","unstructured":"Thathiah A, Brayman M, Dharmaraj N, Julian JJ, Lagow EL, Carson DD. Tumor necrosis factor \u03b1 stimulates MUC1 synthesis and ectodomain release in a human uterine epithelial cell lines. Endocrinology. 2004;145:4192\u2013203.","journal-title":"Endocrinology"},{"key":"5611_CR28","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.exer.2009.12.009","volume":"90","author":"AC Albertsmeyer","year":"2010","unstructured":"Albertsmeyer AC, Kakkassery V, Spurr-Michaud S, Beeks O, Gipson IK. Effect of pro-inflammatory mediators on membrane-associated mucins expressed by human ocular surface epithelial cells. Exp Eye Res. 2010;90:444\u201351.","journal-title":"Exp Eye Res"},{"key":"5611_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.aanat.2007.05.001","volume":"190","author":"F Paulsen","year":"2008","unstructured":"Paulsen F, J\u00e4ger K, Worlitzsch D, Br\u00e4uer L, Schulze U, Sch\u00e4fer G, Sel S. Regulation of MUC16 by inflammatory mediators in ocular surface epithelial cell lines. Ann Anat. 2008;190:59\u201370.","journal-title":"Ann Anat"},{"key":"5611_CR30","first-page":"566","volume":"2","author":"I Matte","year":"2012","unstructured":"Matte I, Lane D, Laplante C, Rancourt C, Pich\u00e9 A. Profiling of cytokines in human epithelial ovarian cancer ascites. Am J Cancer Res. 2012;2:566\u201380.","journal-title":"Am J Cancer Res"},{"key":"5611_CR31","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1186\/s12885-015-1511-7","volume":"15","author":"D Lane","year":"2015","unstructured":"Lane D, Matte I, Garde-Granger P, Laplante C, Carignan A, Rancourt C, Pich\u00e9 A. Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers. BMC Cancer. 2015;15:492.","journal-title":"BMC Cancer"},{"key":"5611_CR32","first-page":"2875","volume":"29","author":"RL Giuntoli","year":"2009","unstructured":"Giuntoli RL, Webb TJ, Zoso A, Rogers O, Diaz-Montes TP, Bristow RE, Oelke M. Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity. Anticancer Res. 2009;29:2875\u201384.","journal-title":"Anticancer Res"},{"key":"5611_CR33","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jviromet.2015.08.014","volume":"224","author":"SC Taylor","year":"2015","unstructured":"Taylor SC, Carbonneau J, Shelton DN, Boivin G. Optimization of Droplet Digital PCR from RNA and DNA extracts with direct comparison to RT-qPCR: Clinical implications for quantification of Oseltamivir-resistant subpopulations. J Virol Methods. 2015;224:58\u201366.","journal-title":"J Virol Methods"},{"key":"5611_CR34","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/ijc.29385","volume":"137","author":"I Matte","year":"2015","unstructured":"Matte I, Lane D, Laplante C, Garde-Granger P, Rancourt C, Pich\u00e9 A. Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and \u2013independent mechanisms. Int J Cancer. 2015;137:289\u201398.","journal-title":"Int J Cancer"},{"key":"5611_CR35","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/jcb.25213","volume":"116","author":"PJ Chapela","year":"2015","unstructured":"Chapela PJ, Broaddus RR, Hawkins SM, Lessey BA, Carson DD. Cytokine stimulation of MUC4 expression in human female reproductive tissue carcinoma cell lines and endometrial cancer. J Cell Biochem. 2015;116:2649\u201357.","journal-title":"J Cell Biochem"},{"key":"5611_CR36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1476-4598-11-24","volume":"11","author":"S Kunigal","year":"2012","unstructured":"Kunigal S, Ponnusamy MP, Momi N, Batra SK, Chellappan SP. Nicotine, IFN-\u03b3 and retinoic acid mediated induction of MUC4 in pancreatic cancer requires E2F1 and STAT-1 transcription factors and utilize different signaling cascades. Mol Cancer. 2012;11:24.","journal-title":"Mol Cancer"},{"key":"5611_CR37","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.bbamcr.2008.05.020","volume":"1783","author":"R Mejias Luque","year":"2008","unstructured":"Mejias Luque R, Peiro S, Vincent A, Van Seuningen I, de Bolos C. IL-6 induces MUC4 expression through gp130\/STAT3 pathway in gastric cancer cell lines. Biochim Biophys Acta. 2008;1783:1728\u201336.","journal-title":"Biochim Biophys Acta"},{"key":"5611_CR38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/jcb.25622","volume":"118","author":"M Morgado","year":"2017","unstructured":"Morgado M, Carson DD. PPAR\u03b3 modulation of cytokine-stimulated MUC16 (CA125) expression in breast and ovarian cancer-derived cells. J Cell Biochem. 2017;118:163\u201371.","journal-title":"J Cell Biochem"},{"key":"5611_CR39","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/ijc.22840","volume":"121","author":"D Lane","year":"2007","unstructured":"Lane D, Robert V, Grondin R, Rancourt C, Pich\u00e9 A. Malignant ascites protect against TRAIL-induced apoptosis by activating the PI3K\/Akt pathway in human ovarian carcinoma cells. Int J Cancer. 2007;121:1227\u201337.","journal-title":"Int J Cancer"},{"key":"5611_CR40","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1038\/onc.2010.107","volume":"29","author":"D Lane","year":"2010","unstructured":"Lane D, Goncharenko-Khaider N, Rancourt C, Pich\u00e9 A. Ovarian cancer ascites protects from TRAIL-induced cell death through \u03b1v\u03b25 integrin-mediated focal adhesion kinase and Akt activation. Oncogene. 2010;29:3519\u201331.","journal-title":"Oncogene"},{"key":"5611_CR41","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1093\/ndt\/gfl715","volume":"22","author":"AH Yang","year":"2007","unstructured":"Yang AH, Huang SW, Chen JY, Lin JK, Chen CY. Leptin augments myofibroblastic conversion and fibrogenic activity of human peritoneal mesothelial cells: a functional implication for peritoneal fibrosis. Nephrol Dial Transplant. 2007;22:756\u201362.","journal-title":"Nephrol Dial Transplant"},{"key":"5611_CR42","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12943-016-0542-2","volume":"15","author":"D Lane","year":"2016","unstructured":"Lane D, Matte I, Laplante C, Garde-Granger P, Carignan A, Bessette P, Rancourt C, Pich\u00e9 A. CCL18 from ascites promotes ovarian cancer cell migration through proline-rich tyrosine kinase 2 signaling. Mol Cancer. 2016;15:58.","journal-title":"Mol Cancer"},{"key":"5611_CR43","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1111\/j.1398-9995.2008.01781.x","volume":"63","author":"M Dogru","year":"2008","unstructured":"Dogru M, Matsumoto Y, Okada N, Igarashi A, Fukagawa K, Shimazaki J, Tsubota K, Fujishima H. Alterations of the ocular surface epithelial MUC16 and goblet cell MUC5AC in patients with atopic keratoconjunctivitis. Allergy. 2008;63:1324\u201334.","journal-title":"Allergy"},{"key":"5611_CR44","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1167\/iovs.02-0862","volume":"44","author":"P Arg\u00fceso","year":"2003","unstructured":"Arg\u00fceso P, Spurr-Michaud S, Russo CL, Tisdale A, Gipson IK. MUC16 mucin is expressed by the human ocular surface epithelia and carries the H185 carbohydrate epitope. Invest Ophtalmo & Vis Sci. 2003;44:2487\u201395.","journal-title":"Invest Ophtalmo & Vis Sci"},{"key":"5611_CR45","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/j.biocel.2007.05.013","volume":"39","author":"JR Davies","year":"2007","unstructured":"Davies JR, Kirkham S, Svitacheva N, Thornton DJ, Carlstedt I. MUC16 is produced in tracheal surface epithelium and submucosal glands and is present in secretions from normal human airway and cultured bronchial epithelial cells. Int J Biochem and Cell Biol. 2007;39:1943\u201354.","journal-title":"Int J Biochem and Cell Biol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5611-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5611-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5611-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T09:46:33Z","timestamp":1589881593000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5611-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,30]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5611"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5611-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,30]]},"assertion":[{"value":"18 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by our Institutional Review Board named \u00abComit\u00e9 d\u2019\u00e9thique de la recherche du CIUSSS de l\u2019Estrie \u2013 CHUS\u00bb. Informed written consent was obtained from women that underwent surgery by the gynecologic oncology service between 2000 and 2017. The committee reference number of this project is #1999\u201311, 98\u201351.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"406"}}